Financial Performance - The company's revenue for the year ended December 31, 2025, was HKD 157,200,000, compared to HKD 149,945,000 for 2024, representing an increase of approximately 4.2%[2] - The gross profit for 2025 was HKD 42,453,000, up from HKD 35,680,000 in 2024, indicating a growth of about 19.0%[2] - The total annual loss for 2025 was HKD 101,996,000, a decrease from HKD 115,575,000 in 2024, reflecting an improvement of approximately 11.7%[3] - The basic and diluted loss per share improved to HKD 1.67 in 2025 from HKD 1.92 in 2024, indicating a positive trend[4] - The total comprehensive loss for the year was HKD 55,089,000 in 2025, a significant reduction from HKD 158,183,000 in 2024, reflecting an improvement of approximately 65.2%[4] Assets and Liabilities - Non-current assets totaled HKD 1,752,679,000 in 2025, an increase from HKD 1,398,050,000 in 2024, marking a growth of about 25.3%[5] - Cash and cash equivalents rose to HKD 140,538,000 in 2025 from HKD 77,865,000 in 2024, representing an increase of approximately 80.3%[5] - The company's total liabilities decreased to HKD 1,000,000,000 in 2025 from HKD 1,200,000,000 in 2024, indicating a reduction of about 16.7%[5] - Current liabilities increased to HKD 272,424,000 in 2025 from HKD 138,011,000 in 2024, representing a growth of 97.5%[6] - Non-current liabilities decreased to HKD 70,690,000 in 2025 from HKD 71,729,000 in 2024, a decline of 1.45%[6] Revenue Breakdown - Revenue from product sales was HKD 142,398,000 in 2025, up from HKD 135,907,000 in 2024, indicating a growth of approximately 4.3%[16] - Revenue from service provision was HKD 14,802,000 in 2025, compared to HKD 14,038,000 in 2024, reflecting an increase of about 5.4%[16] - The group recognized revenue of HKD 29,490,000 in 2025, down from HKD 40,018,000 in 2024, indicating a decline of approximately 26.2%[16] - Other income totaled HKD 35,440,000 in 2025, an increase from HKD 30,095,000 in 2024, representing a growth of approximately 17.8%[20] Elderly Care Segment - The company operates and manages seven elderly care institutions in China, providing a total of 1,373 beds, primarily located in the Yangtze River Delta region[48] - Revenue from elderly care institutions for the year was RMB 55.31 million, a year-on-year increase of approximately 23% compared to RMB 45.08 million in 2024[48] - Net profit for the elderly care segment was RMB 3.31 million, up about 55% from RMB 2.14 million in 2024, driven by increased bed capacity and occupancy rates[48] - The average occupancy rate of the company's elderly care institutions reached approximately 75%, reflecting stable operational cash flow and high asset utilization[48] Investments and Acquisitions - The company has entered into a supplemental agreement regarding the joint venture 1121695 B.C. Ltd., which will be treated as a subsidiary, allowing the company to control the majority of the board[32][34] - The company sold its subsidiary United Win International Corporation for approximately HKD 16,924,000, resulting in a loss of about HKD 21,369,000[37] - The net cash inflow from the sale of the subsidiary was HKD 16,912,000 after accounting for cash and cash equivalents sold[39] Market Opportunities - The elderly population in China surpassed 300 million in 2025, projected to exceed 400 million by 2035, indicating a significant market opportunity in the silver economy[46] - The government has emphasized the development of elderly care services, with a market size expected to exceed RMB 30 trillion in the future, indicating a favorable policy environment[46] Operational Efficiency - The group aims to increase the total number of elderly care beds to over 5,000 in the short term, with a medium-term goal of exceeding 10,000 beds and a long-term vision of reaching 100,000 beds[69] - The group has initiated online value-added service platforms to provide comprehensive elderly care services, aiming to enhance service revenue and customer loyalty[67] Financial Management - The group will not increase investments in health industry parks in China due to an uncertain macro environment but will seek suitable partners for potential project sales[69] - The board does not recommend a final dividend for the year ending December 31, 2025, maintaining sufficient financial resources for future business development[99] Miscellaneous - The audit committee has reviewed the group's full-year performance for the year ending December 31, 2025[101] - The company's annual report for the year ending December 31, 2025, will be sent to shareholders and published on the Hong Kong Stock Exchange and the company's website[103] - Forward-looking statements in the announcement reflect the board's current beliefs, assumptions, and expectations based on industry and market conditions, which may differ significantly from actual results due to risks and uncertainties[105]
北京健康(02389) - 2025 - 年度业绩